1. Leithner D,
Wengert GJ,
Helbich TH,
Thakur S,
Ochoa-Albiztegui RE,
Morris EA,
Pinker K.
Clinical role of breast MRI now and going forward.
Clin Radiol. 2018;73:700-714
2. Mann RM,
Balleyguier C,
Baltzer PA,
Bick U,
Colin C,
Cornford E,
Evans A,
Fallenberg E,
Forrai G,
Fuchsjäger MH,
Gilbert FJ,
Helbich TH,
Heywang-Köbrunner SH,
Camps-Herrero J,
Kuhl CK,
Martincich L,
Pediconi F,
Panizza P,
Pina LJ,
Pijnappel RM,
Pinker-Domenig K,
Skaane P,
Sardanelli F.
Breast MRI: EUSOBI recommendations for women’s information.
Eur Radiol.
2015; 25:3669-78
3. Sardanelli F,
Boetes C,
Borisch B,
Decker T,
Federico M,
Gilbert FJ,
Helbich T,
Heywang-Köbrunner SH,
Kaiser WA,
Kerin MJ,
Mansel RE,
Marotti L,
Martincich L,
Mauriac L,
Meijers-Heijboer H,
Orecchia R,
Panizza P,
Ponti A,
Purushotham AD,
Regitnig P,
Del Turco MR,
Thibault F,
Wilson R.
Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working group.
Eur J Cancer.
2010; 46:1296-316
4. Rahbar H,
Partridge SC,
Demartini WB,
Thursten B,
Lehman CD.
Clinical and technical considerations for high quality breast MRI at 3 Tesla.
J.
Magn.
Reson.
Imaging. 2013; 37:778-90
5. Matsuoka A,
Minato M,
Harada M,
Kubo H,
Bandou Y,
Tangoku A,
Nakano K,
Nishitani H.
Comparison of 3.0-and 1.5-tesla diffusion-weighted imaging in the visibility of breast cancer.
Radiat Med - Med Imaging Radiat Oncol.
2008; 26:15-20
6. Bogner W,
Gruber S,
Pinker K,
Grabner G,
Stadlbauer A,
Weber M,
Moser E,
Helbich TH,
Trattnig S.
Diffusion-weighted MR for Differentiation of Breast Lesions at 3.0 T: How Does Selection of Diffusion Protocols Affect Diagnosis? Radiology.
2009; 253:341-51
7. ACR BI-RADS Atlas,
breast imaging reporting and data system.
Reston,
VA,
Am.
Coll.
Radiol.
2013